Phase 3 Readout

INSP: Phase 3 Topline: Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive

Name: Phase 3 Topline: Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive
Start: 2027-09-30
End: 2027-09-30

September 30, 2027. BioSniper AI can trace the company-impact path without requiring you to write the research question.

Event date: September 30, 2027
Company: Inspire Medical Systems Inc. (INSP)

BioSniper AIPage evidence connected

Prepared research question

What could this event change, and which evidence should be watched next?

Run cited research

Traceable citations · Unknowns marked

Phase 3 Readout~month

Phase 3 Topline: Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive

September 30, 2027

INSP overview →

Company: Inspire Medical Systems Inc. (INSP)
Indication: Down Syndrome; Obstructive Sleep Apnea